RA development is a continuous, progressive, systemic pathology process and multiple autoantibodies, including rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA), are detectable in serum before the onset or in the early stage of RA (3–5). The gene discussed is PRTN3; the disease is rheumatoid arthritis.